Stock·NYSE·Financial Services
ICICI Bank Ltd (IBN)
- Market cap
- $105.11B
- Dividend yield
- None
- Street target
- $36.50median of 4 analysts
- 52-week range
- $25.08 $31.78
IBN stock forecast today
Where IBN stands today, and what CleaRank Financial AI makes of it.
IBN at a glance
ICICI Bank Ltd (IBN): Buy, 74/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($28.95 and $28.55).
- Earnings IBN beat estimates in 6 of the 6 reports in our data, yet fell the next day after 1 of those beats.
Figures as of October 26, 2026.
CleaRank Financial AI
IBN earns a CleaRank rating of Buy with a model score of 74/100.
The analysts' outlook lifts that score the most, since 4 of 4 analysts rate the stock a buy and the median target is 24.7% above the price. The trend is up, with the price 1.16% above its 50-day average of $28.95 and 2.57% above its 200-day average of $28.55. Looking back over the past year, the price fell 6.30%.
Only on CleaRank
Figures we compute ourselves from IBN's own price, earnings and insider-filing history. Tap one to see it in context.
IBN stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $29.28 is 1.2% above the 50-day simple moving average of $28.95.Price above its 200-day average ›
The price is 2.6% above the 200-day simple moving average of $28.55.50-day average above the 200-day ›
The 50-day average ($28.95) is 1.4% above the 200-day average ($28.55), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 63% of its 52-week range, between $25.08 and $31.78.
IBN share price
Pick a period: each tab shows how far IBN has moved over it, to the last close.
Today's trading
Where IBN sits inside today's range and its 52-week range.
IBN fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/2P/S below the sector median ›
The price-to-sales ratio of 4.70 is 23.8% above the sector median of 3.8.Beat estimates in most recent reports ›
IBN beat the EPS estimate in 6 of the 6 reports in our data.
Key statistics
The headline figures for IBN.
As of October 26, 2026, IBN trades at $29.28, with a market value of $105.11B.
What the numbers say
CleaRank Financial AI's reading of IBN's valuation, growth and risks.
Measured against sales, its P/S of 4.70 sits 23.7% above the sector median of 3.8.
On profitability, the net margin stands at 41.5% and the operating margin at 37.52%.
IBN beat expectations in its October 17, 2026 report by 13.16%, with EPS of $0.43 against an estimate of $0.38. In the first session after the report, the share price went up 1.36%.
The record is a clean sweep: 6 beats in 6 reports, but beats have not guaranteed gains: the stock fell the next day after 1 of them. Analysts' average EPS estimate for this fiscal year is $1.73, which would be growth of 15.8%, and $2.01 for next year (growth of 16.1%).
On a typical day the price of IBN shifts by 1.27%, the 30-day standard deviation of its daily returns; measured against the S&P 500, its beta is 0.26.
IBN against the Financial Services sector
How IBN compares with the median Financial Services stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, IBN trades at 4.70x, +24% versus the sector average of 3.80x.
Return vs XLF: Since May 14, 2025, IBN has lost 12.2% against a gain of 9.9% for XLF.
Performance against XLF
IBN and the Financial Services sector fund over the same days.
Revenue and earnings
How much IBN sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); IBN reported again on October 17, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 22.6% in FY2026 to ₹2.23T, from ₹1.82T a year earlier.
Profit margin: The net margin was 25.9% in FY2026, down from 30.0% the year before.
Profitable: IBN earned ₹579B in FY2026.
Earnings reality check
Did IBN beat what analysts expected, and how did the stock react?
Earnings record: IBN beat the analyst estimate in 6 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 1 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 17, 2026after close | $0.38 | $0.43 | +13.16% | +1.36% | -0.68% |
| Jul 18, 2026after close | $0.41 | $0.42 | +2.44% | +0.97% | +0.44% |
| Oct 18, 2025after close | $0.36 | $0.39 | +8.33% | +0.77% | +0.42% |
| Jul 19, 2025after close | $0.39 | $0.41 | +5.13% | -0.38% | -1.11% |
| Apr 19, 2025after close | $0.37 | $0.41 | +10.81% | +1.64% | -0.03% |
| Jan 25, 2025after close | $0.35 | $0.38 | +8.57% | +1.83% | +1.66% |
As of October 26, 2026, IBN has beaten the analyst EPS estimate in 6 of the 6 reports in our data and fell in the first trading session after 1 of those beats; its latest report, on October 17, 2026, came in 13.16% above the estimate and the stock moved +1.36% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
IBN AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 54.6, in neutral territory.RSI above 50 ›
An RSI of 54.6 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of IBN
The score, the reasoning behind it, and what could move the price next.
ICICI Bank Ltd (IBN) is in an uptrend. The price of $29.28 sits 1.16% above its 50-day average of $28.95 and 2.57% above its 200-day average of $28.55. That 50-day average is 1.40% above the 200-day average. Across its 52-week range, which runs from $25.08 to $31.78, the stock is at 63% of the way up.
Recent gains sit against a weaker longer record: the price rose 4.87% over the past month, fell 2.04% over the past three months and fell 6.30% over the past year. On momentum, the 14-day RSI reads 54.6, in the neutral zone, with the MACD line positive.
Earnings beat ›
The October 17, 2026 report beat the EPS estimate by 13.16%, and the share price rose 1.36% in the first session after it.
Source: Earnings report, October 17, 2026
- Two levels matter most right now: the 52-week high at $31.78, which sits above the price, and the 20-day EMA at $28.95, which sits below it.
- The 14-day RSI reads 54.6, in the neutral zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- The share price went up 1.36% in the first session after the October 17, 2026 report. Over the 6 reports in our data, IBN beat estimates in 6.
IBN trades above its 50-day and 200-day moving averages ($28.95 and $28.55), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 20-day EMA at $28.95.
The next level overhead for IBN is its 52-week high of $31.78.
Technical indicators
Momentum and trend for IBN, from its daily closes.
As of October 26, 2026, with IBN at $29.28, its 14-day RSI is 54.6 (neutral territory), its 50-day simple moving average is $28.95 and its 200-day is $28.55.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What IBN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, IBN's 1-year correlation of daily returns is +0.31 with S&P 500 (SPY), +0.23 with Nasdaq 100 (QQQ), +0.17 with Bitcoin (BTC) and +0.06 with gold (XAU).
IBN price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
4 of 4 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $36.50 is 24.7% above the price.More buy ratings than three months ago ›
4 of 4 rate it a buy now, against 4 of 4 three months ago.
IBN Wall Street View
12-month price targets
The price, $29.28, sits below every analyst's target.
Ratings
As of October 26, 2026, 4 Wall Street analysts cover IBN: 4 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $35.30 to $40.00. The median IBN price target is $36.50, 24.7% above the price of $29.28.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
IBN trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
IBN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from IBN's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much IBN tends to move, against the market and on its own.
IBN price history and drawdowns
IBN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.27% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 52.7%, from December 2019 to March 2020, regained by January 2021.Most 1-year holds ended higher ›
75% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $40,289, against $42,015 in the S&P 500 (SPY).
IBN Drawdowns & Recovery
As of October 26, 2026, IBN's worst peak-to-trough fall over the last 10 years with dividends reinvested was -52.7% (December 2019 to March 2020); it regained that peak by January 2021, 10 months after the low, and 75% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into IBN in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: IBN trailed the S&P 500 over this period: $40,289 against $42,015.
A $10,000 investment in IBN in October 2016 would be worth about $40,289 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to IBN, and which have not.
Strongest month, July: an average of +5.45%, up in 10 of 10 years.
Weakest month, March: an average of -3.60%, up in 5 of 10 years.
This month, October: has averaged +4.94%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, IBN's strongest calendar month has been July (average +5.45%, up in 10 of 10 years) and its weakest March (average -3.60%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
IBN stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in IBN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in IBN today could grow to about $14,154 by 2030 in the base case, with a 90th-percentile outcome near $31,407 and a 10th-percentile outcome around $6,378. Projections are statistical simulations, not guarantees.
IBN Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $41.44 for IBN by 2030 in the base case, from $29.28 today (1.4x over 4 years). The 10th-percentile path ends near $18.68. These are outcomes of a Monte Carlo simulation run on IBN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $21.44 | $31.94 | $47.57 | |
| 2028 | $19.83 | $34.83 | $61.20 | |
| 2029 | $19.05 | $37.99 | $75.77 | |
| 2030 | $18.68 | $41.44 | $91.96 |
Method: a lognormal simulation of IBN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
IBN stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.